ME Therapeutics Holdings Inc. ("ME Therapeutics" or the "Company") (CSE: METX) (FSE: Q9T), a publicly listed preclinical ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

The DNA is basically a book of recipes. Each recipe tells the cells in our bodies how to make specific proteins by combining ...

Immunologists from the Institute have been the first to uncover a role for a family of RNA binding proteins in the function ...

Biomedical engineers at Georgia Tech created a treatment that could one day unlock a universal strategy for treating some of ...

REGIONS NEWS OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA Technologies OSE ...

In arm 1 of the trial, the dose-escalation portion, patients will receive mRNA-4106 at a test dose as monotherapy. In arm 2, ...

While global giants like Moderna and BioNTech apply mRNA technology to broader disease markets, PRC's mRNA frontrunner is keeping pace. AIM Vaccine (06660.HK), a leading domestic vaccine company, ...

Breakthrough approval highlights the power of AIM’s next-gen platform and global ambition in biotech innovation.